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Abstract
Background: Modern obstetrics is faced with a serious paradox. Obstetric practice is becoming
increasingly interventionist based on empirical evidence but without a theoretical basis for such
intervention. Whereas obstetric models of perinatal death show that mortality declines
exponentially with increasing gestational duration, temporal increases in medically indicated labour
induction and cesarean delivery have resulted in rising rates of preterm birth and declining rates of
postterm birth. Other problems include a disconnection between patterns of gestational age-
specific growth restriction (constant across gestation) and gestational age-specific perinatal
mortality (exponential decline with increasing duration) and the paradox of intersecting perinatal
mortality curves (low birth weight infants of smokers have lower neonatal mortality rates than the
low birth weight infants of non-smokers).
Discussion: The fetuses at risk approach is a causal model that brings coherence to the various
perinatal phenomena. Under this formulation, pregnancy complications (such as preeclampsia),
labour induction/cesarean delivery, birth, revealed small-for-gestational age and death show
coherent patterns of incidence. The fetuses at risk formulation also provides a theoretical
justification for medically indicated early delivery, the cornerstone of modern obstetrics. It permits
a conceptualization of the number needed to treat (e.g., as low as 2 for emergency cesarean
delivery in preventing perinatal death given placental abruption and fetal bradycardia) and a
calculation of the marginal number needed to treat (i.e., the number of additional medically
indicated labour inductions/cesarean deliveries required to prevent one perinatal death). Data from
the United States showed that between 1995–96 and 1999–2000 rates of labour induction/
cesarean delivery increased by 45.1 per 1,000 and perinatal mortality decreased by 0.31 per 1,000
total births among singleton pregnancies at > = 28 weeks of gestation. The marginal number needed
to treat was 145 (45.1/0.31), showing that 145 excess labour inductions/cesarean deliveries in
1999–2000 (relative to 1995–96) were responsible for preventing 1 perinatal death among
singleton pregnancies at > = 28 weeks gestation.
Summary:  The fetuses at risk approach, with its focus on incidence measures, provides a
coherent view of perinatal phenomena. It also provides a theoretical justification for medically
indicated early delivery and reconciles the contemporary divide between obstetric theory and
obstetric practice.
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1. Background
Increases in medically indicated labor induction and
cesarean delivery in recent decades have resulted in
increases in preterm (< 37 weeks) birth rates, while births
at term (37–41 weeks) and postterm (≥ 42 weeks) gesta-
tion are also being delivered much earlier than previously
[1-10]. However, such changes in obstetric practice are not
consistent with obstetric theory since traditional obstetric
models of perinatal death show that perinatal mortality
rates decrease exponentially as gestational age increases
[11-14]. This paper examines the 'paradox of modern
obstetrics' [15] and various other conundrums within
perinatology and discusses the 'fetuses at risk approach' as
a potential solution. The latter approach is an epidemio-
logic formulation that identifies fetuses as the candidates
for perinatal events (as opposed to the traditional obstet-
ric and epidemiologic models that typically focus on new-
borns as the candidates for perinatal events). The fetuses
at risk approach provides a coherent framework for recon-
ciling the diverse set of problems facing perinatology
[15,16] and for developing a coherent epidemiologic
framework for justifying medically indicated early deliv-
ery.
1.1. The paradox of modern obstetrics
The cornerstone of modern obstetrics is selective, carefully
timed early delivery given fetal compromise (maternal
indications sometimes necessitate early delivery as well).
Medically indicated labor induction and cesarean delivery
are typically employed when the balance of risks and ben-
efits indicate that birth and supportive neonatal care are
preferable to an intrauterine environment that is adversely
affecting fetal well-being.
Induction of labor to effect early delivery was introduced
in the mid-18th century as a management option for con-
tracted pelvis [17]. In the 1950s, early delivery after 35
weeks gestation was routinely used to prevent stillbirth in
severe cases of Rh hemolytic disease [18]. More recently,
with advances in the diagnosis of fetal compromise (bio-
physical profile, umbilical artery Doppler velocimetry,
etc) and in neonatal care (antenatal corticosteroids, sur-
factant, assisted ventilation, etc), rates of medically indi-
cated labor induction and cesarean delivery have
increased substantially in industrialized countries at pre-
term, term and postterm gestation [1-10,19]. The conse-
quent "left-shift" in the population distribution of
gestational age at birth (Figure 1a) has been responsible
for the well-recognized phenomenon of rising preterm
birth rates and declining postterm birth rates in industri-
alized countries. In Canada, preterm birth rates among
twins and higher order multiple births have increased
monotonically from approximately 30% in the 1970s, to
40% in the early 1980s, to 50% in the 1990s and to
approximately 55% currently [1-4]. Substantial changes
have occurred in the gestational age distribution of single-
tons as well, with increases in preterm birth rates from 5.6
percent in 1981–83 to 6.4 percent in 2000, and declines
in postterm birth rates from 6.0 percent in 1981–83 to 1.2
percent in 2000 [1,2,4]. Most of the latter decline in post-
term births has occurred due to the introduction of a pol-
icy of routine labour induction for postterm pregnancies
[10] (although changes in the modality of gestational age
ascertainment, from menstrual dating to ultrasound dat-
ing, have contributed as well [20]).
However, traditional epidemiologic and obstetric models
of perinatal death do not support this iatrogenic increase
in early delivery [11-14]. Such models show that the rate
of gestational age-specific perinatal mortality (calculated
by dividing the number of perinatal deaths at any gesta-
tion by the number of total births at that gestation)
decreases exponentially as gestational age advances (Fig-
ure 1b). Although such models provide a justification for
early delivery at ≥ 41 weeks for singletons and at ≥ 39
weeks for twins (Figure 1b), they suggests that a left-shift
in the gestational distribution in the preterm or term ges-
tational age range will lead to increases in overall perina-
tal mortality rates. For instance, early delivery at 34 weeks
instead of 36 weeks gestation (or early delivery of single-
tons at 38 instead of 40 weeks) implies a substantially
higher perinatal mortality rate (note log scale, Figure 1b).
In fact, the recent left-shift in the gestational age distribu-
tion in Canada and in the United States (due to increases
in labor induction and cesarean delivery) was accompa-
nied by a decline in perinatal mortality [1,4,7-9,21-23].
1.2. Other apparently contradictory phenomena in the 
perinatology
The paradox of modern obstetrics is also evident in rela-
tion to cerebral palsy. Although preterm birth is highly
associated with cerebral palsy and deemed to be an
important cause of cerebral palsy [11,24], the rising rate of
preterm birth (especially among twins) has not resulted in
an epidemic of cerebral palsy. Related conundrums are
evident in the literature on fetal growth restriction
[15,16]. The methods used to identify small-for-gesta-
tional age (SGA) live births (< 3rd or < 10th percentile of
birth weight for gestational age) suggest that a fixed frac-
tion of births (approximately 3% or 10% depending on
the cut-off used) are growth restricted at each gestation.
Such an implied constancy of the growth restriction rate
across gestation is at odds with an exponentially declining
rate of gestational age-specific perinatal mortality. Clearly,
this incongruence between patterns of in utero growth fal-
tering and death needs to be reconciled, given the known
relationship between fetal growth restriction and perina-
tal death [25,26].BMC Pregnancy and Childbirth 2007, 7:4 http://www.biomedcentral.com/1471-2393/7/4
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Gestational age distribution (1a) and gestational age-specific perinatal mortality (1b and 1c) rates, Canada Figure 1
Gestational age distribution (1a) and gestational age-specific perinatal mortality (1b and 1c) rates, Canada. 
Gestational age distribution of twin live births in Canada 1985–88 versus 1996–98 (Figure 1a), conventional calculation of ges-
tational age-specific perinatal mortality rates per 1,000 total births among singletons and twins, Canada 1991–97 (Figure 1b), 
and gestational age-specific rates of revealed small-for-gestation age (SGA, primary Y-axis) and perinatal death (secondary Y-
axis) per 1,000 fetuses at risk among singletons and twins, Canada 1991–97 (Figure 1c). Reprinted with permission [16].
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Other problems in the fetal growth literature relate to fetal
growth standards. Some fetal growth standards provide
unisex reference values [27-30], several are sex-specific
[25,31-40] and yet others provide both sex-specific and
unisex reference values [41-44]. Of equal concern is the
fact that several fetal growth standards are customized for
different races [25,31,33-36], parity [31,33,35,40,42],
plurality [30,36] and other characteristics [30,33], while
others are not [27-29,32,37-39,41,43].
Perhaps the most intriguing of the paradoxes in the peri-
natal literature is presented by intersecting birth weight-
and gestational age-specific perinatal mortality curves.
Birth weight-and gestational age-specific perinatal mortal-
ity curves intersect [45] when contrasts are made by smok-
ing status, plurality (Figure 1b), race, parity, infant sex,
country, etc. This phenomenon was first identified by
Yerushalmy [46] who showed that whereas, at low birth
weight, infants of smokers have a lower neonatal mortality
rate than infants of non-smokers, the reverse is true at
higher birth weight. Are the low birth weight or preterm
infants of smokers more healthy than the low birth weight
or preterm infants of nonsmokers? Addressing the para-
dox of intersecting perinatal mortality curves is important
because the resolution of scientific paradoxes often leads
to greater substantive insights. The contemporary appeal
of traditional models notwithstanding, intersecting peri-
natal mortality curves (and the other above-mentioned
conundrums) suggest that there may be a more compel-
ling perspective on perinatal events.
2. Discussion
2.1 Problems with traditional models
The conundrums and paradoxes evident in contemporary
perinatology are, at least partly, a consequence of the
manner in which time related concepts are addressed in
traditional models.
2.1.1. Time scales and anchors
Two time scales are commonly used in perinatology and
these measure the duration of life in utero (gestational
age, which is anchored to the first day of the last men-
strual period) and the duration of life after birth (chrono-
logic age, which is anchored to birth). The clinical
problems caused by these dual overlapping scales are gen-
erally recognized, especially by clinicians in neonatology,
who resort to a single scale for expressing age, namely,
post-menstrual age or corrected gestational age. Such rec-
ognition is also reflected in the evolution of Bronchopul-
monary Dysplasia, which was historically defined as a
requirement for oxygen at more than 28 days after birth
but now refers to a requirement for oxygen or ventilatory
support at 36 weeks of post-menstrual age [47]. An impor-
tant aspect of the use of dual time scales that is not related
to duration issues is the qualitative label that is assigned
to death depending on whether death occurs before or
after the second time scale becomes operational. Thus, a
fetus who dies in utero at 38 weeks is a stillbirth but
another who dies at 2 weeks of chronologic age after birth
at 36 weeks is a neonatal death. Birth has a preeminent
position in qualifying life events for reasons that appear to
be more sociologic than biologic.
2.1.2. Status of gestational age: determinant versus survival time
Gestational age is often treated as a determinant in perina-
tal epidemiologic studies. As a determinant, gestational
age at birth (and birth weight, which is closely correlated
with gestational age) serves as a powerful predictor of
death and other adverse perinatal outcomes. However,
from an epidemiologic perspective, gestational age is in
fact follow up (survival) time and should be treated as
such in causal models.
2.2. The fetuses at risk approach
The problem inherent in calculating traditional gesta-
tional age-specific stillbirth rates (e.g., using the number
of stillbirths and live births at 32 weeks as the denomina-
tor for the stillbirth rate at 32 weeks) and equating these
estimates with gestational age-specific stillbirth risk was
first identified over 15 years ago [48]. Yudkin et al [48]
proposed that all fetuses delivered and undelivered at the
gestational age of interest are at risk of fetal death at that
gestation and constitute the denominator for calculating
the risk of stillbirth at that gestational age (Figure 2). This
'fetuses at risk' formulation for stillbirth is widely recog-
nized and accepted in the literature [49-55], although the
traditional formulation has numerous adherents as well
[11-14,56]. More recently, Yudkin's formulation [48] has
been extended beyond stillbirth to include the estimation
of incidence rates for various perinatal phenomena
including birth, growth restriction, and perinatal death
[15].
2.2.1. Incidence of birth, labour induction, pregnancy complications
The incidence rate of any pregnancy related event at any
gestation is defined as the number of new cases of the
event that occur within that gestational week divided by
the number of candidates at risk for the event at that ges-
tation. Thus, the incidence of birth (Tables 1, 2) is calcu-
lated by dividing the number of births at any gestation by
the number of fetuses at risk of birth at that gestation
[15,57,58]. The concept is appropriately extended to all
relevant perinatal phenomena including the incidence of
labor induction, cesarean delivery [15,59] and pregnancy
complications (such as hyperemesis gravidarum [60]
preeclampsia and chorioamnionitis [61,62], Figure 3). In
fact, documenting the incidence pattern of most preg-
nancy complications over the course of pregnancy has not
been undertaken seriously. Although the exact time when
a pregnancy complication occurs may sometimes be diffi-BMC Pregnancy and Childbirth 2007, 7:4 http://www.biomedcentral.com/1471-2393/7/4
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cult to ascertain, this is not a sufficient reason for aban-
doning the study of the incidence patterns of pregnancy
complications.
2.2.2. The incidence of growth restriction
The incidence of growth restriction is a good example of
an index whose estimation presents a challenge. Although
Schematic depiction of pregnancy course and options for calculating the gestational age-specific stillbirth rate Figure 2
Schematic depiction of pregnancy course and options for calculating the gestational age-specific stillbirth rate. 
Traditional calculation: Number of stillbirth at any gestational week/Number of total births at that gestational week = 1/4 = 250 
per 1,000 total births. Fetuses at risk calculation: Number of stillbirths at any gestational week/Number of fetuses at risk of still-
birth at that gestational week = 1/16 = 63 per 1,000 fetuses at risk.
20              30          40
Gestational age (weeks) 
Livebirth
Stillbirth
Risk period
Fetuses at risk model
Stillbirth rate = 1/16 
fetuses at risk
Traditional model
Stillbirth rate =1/4 
total birthsBMC Pregnancy and Childbirth 2007, 7:4 http://www.biomedcentral.com/1471-2393/7/4
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routine obstetric practice includes screening for and diag-
nosis of growth restriction, the technology is insufficiently
advanced to permit valid and complete ascertainment of
all new cases at each gestation [63-65]. Given this limita-
tion, an alternative index, namely, the incidence of
revealed SGA (Tables 1, 2, Figure 1c, Figure 3) may be cal-
culated by dividing the number of SGA births at any ges-
tation by the number of fetuses at risk of SGA birth at that
gestation [15,16,57-59]. The primary utility in estimating
this proxy incidence rate is in order to approximate the
incidence pattern of growth restriction with increasing ges-
tational duration i.e., to estimate whether it increases,
decreases or remains constant. The measure cannot pro-
vide the absolute rate of SGA at any gestation since the
numerator of the index is dependant on birth (hence the
term "revealed"). Improvements in technology will per-
mit quantification of the absolute rate (incidence) of
growth restriction at each gestation in the future.
2.2.3. The incidence of perinatal death
The fetuses at risk approach for stillbirth is a survival anal-
ysis model with censoring of subjects (fetuses) at birth.
This gestational age-specific stillbirth calculation provides
estimates of the cumulative incidence of fetal death at
each week of gestation and approximates the incidence
density (hazard) of stillbirth. The extended fetuses at risk
model integrates perinatal death and serious neonatal
morbidity (e.g., severe respiratory distress syndrome,
severe intraventricular hemorrhage, etc) into a single
framework (Figure 4) since these events all have their ori-
gins in pregnancy, labour or birth [15,16,66,67]. This is
consistent with principles ingrained in routine obstetric
practice and state-of-the-art clinical trials [68,69] where
the definitive obstetric outcome embraces perinatal mor-
tality and serious neonatal morbidity. Similarly, with
recent literature [70-72] suggesting that cerebral palsy has
a predominantly prenatal origin (i.e., critical neurologic
injury occurs before birth), this outcome is also assigned
to the point of birth, despite being diagnosed years later.
Combining stillbirth, neonatal death and serious neona-
tal morbidity into a single composite outcome is consist-
ent with traditions in obstetrics and is justified by the
broadly overlapping multifactorial etiology that charac-
terizes these distinct entities [15].
As mentioned, the extended fetuses at risk model most
deviates from traditional models with respect to events
that occur after birth and yet have a prenatal etiology.
Under the traditional model of perinatal death, neonatal
deaths occur among infants in the first month after birth
and the unborn fetus is not a candidate for neonatal
death. However from a broad biological, obstetric and
ultimately epidemiologic point of view, a fetus at any ges-
tation is at risk of stillbirth and neonatal death at that ges-
tation. If one considers a woman at 28 weeks gestation
with severe preeclampsia and fetal compromise, the risk
of stillbirth is easy to conceptualize. The risk of neonatal
death is substantial as well and can follow either prema-
ture labour or medically indicated delivery. The same risks
apply in concept to a woman with a healthy pregnancy at
28 weeks gestation, despite the magnitude of the risks
being considerably smaller [15]. Thus, although neonatal
deaths literally occur among infants, fetuses can be con-
sidered candidates for neonatal death as well. This is anal-
Table 1: Numbers and rates of perinatal death, live birth and small for gestational age (SGA) live birth among singletons births, 
Canada (excluding Ontario), 1991 to 1997.
Gestational age Stillbirths Neonatal deaths Live births SGA live 
births
Rates (Conventional) Fetuses at 
risk†
Rates (Fetuses at risk)
SGA (%) Perinatal 
mortality per 
1,000
Births per 
1,000
R-SGA per 
1,000
Perinatal 
mortality per 
1,000
34 329 175 10661 1011 9.5 45.9 1583286 6.9 0.6 0.32
35 318 172 18128 1822 10.1 26.6 1572296 11.7 1.2 0.31
36 439 249 41962 4226 10.1 16.2 1553850 27.3 2.7 0.44
37 451 269 87566 9104 10.4 8.2 1511449 58.2 6.1 0.48
38 552 364 232039 22163 9.6 3.9 1423432 163.4 15.6 0.64
39 522 359 356922 35792 10.1 2.5 1190841 300.2 30.2 0.74
40 601 464 536302 54709 10.2 2.0 833397 644.2 65.9 1.28
41 304 219 245665 24104 9.8 2.1 296494 829.6 81.7 1.76
≥ 42 92 77 50433 5250 10.5 3.3 50525 1000.0 104.8 3.34
Total‡ 8694 5562 1614531 160429 10.0 8.8 1623225 1000.0 100.0 8.70
Note: Perinatal mortality includes stillbirths and neonatal deaths. Live births at each gestation served as the denominator for the conventional SGA 
rate and total births at each gestational week served as the denominator for conventional perinatal mortality rate. Under the fetuses at risk 
approach, birth, revealed SGA (R-SGA) and perinatal mortality rates were calculated using the number of fetuses at risk at that gestation as the 
denominator for the rate.
† Calculated by summing the number of fetuses who delivered at that and subsequent gestational weeks.
‡ All gestational ages, including those < 34 weeks and those with missing gestational age.BMC Pregnancy and Childbirth 2007, 7:4 http://www.biomedcentral.com/1471-2393/7/4
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ogous to the calculation of age-specific rates of death from
breast cancer. Such rates are calculated using all women in
the population as the denominator (i.e., as candidates for
death from breast cancer), although one could argue that
death from breast cancer can only occur among women
with breast cancer.
The extended fetuses at risk formulation of death provides
2 alternative models that treat time per epidemiologic
principles (as survival time and on a single time scale). In
the first model, namely, the comprehensive model of
death, time is measured on the scale of post-menstrual (or
post conceptional) age with fetuses/infants censored at
death [15]. Birth is ignored as a event (for truncating the
original time scale) and no distinction is made between
deaths that occur before and after birth. The epidemio-
logic risk set at any point in post-menstrual time is consti-
tuted by the fetuses/infants at risk of death at that point in
time [15]. When this framework is integrated into a pro-
portional hazards model, birth may be introduced as a
time-dependant covariate with time-varying effects [73].
In the second model, namely, the obstetric model of
death, time is measured on the scale of gestational age
with fetuses censored at birth or death. All deaths that
have their origins in prenatal or labour and delivery events
are deemed relevant to obstetrics. Thus, as per traditions
in obstetrics, stillbirths and neonatal deaths (and serious
neonatal morbidity) are assigned to the point of birth. The
epidemiologic risk set for such obstetric outcomes is con-
stituted by the fetuses at risk for such events, namely, all
unborn fetuses at the gestational age in question (Figure
4).
2.2.4. Reconciling diverse perinatal conundrums
The fetuses at risk formulation brings coherence to the
study of perinatal phenomena. It shows that the incidence
of pregnancy complications such as preeclampsia and
chorioamnionitis increases as gestational age advances
[61,62]. Revealed SGA rates also increase with increasing
gestational age (Figure 1c) and presage the rise in perina-
tal mortality rates [15,16,57-59]. Gestational age-specific
perinatal mortality curves do not intersect in comparisons
by smoking status, plurality (Figure 1c), race, parity,
infant sex, etc [57-59]. Smokers have higher rates of
revealed SGA and perinatal death than non-smokers at all
gestational ages [58] and twins [57] have higher rates of
revealed SGA and perinatal death than singletons at all
gestational ages (Figure 1c). Similarly, the incidence of
birth, labor induction and cesarean delivery show patterns
that are congruent with patterns of revealed SGA and
death [15,57-59,67]. The rising patterns of gestational
age-specific revealed SGA and perinatal death also offer a
preliminary justification for medically-indicated early
delivery. Finally, the fetuses at risk approach provides
insights into issues as diverse as the etiology of cerebral
palsy [74] and the need for customized fetal growth stand-
ards [59,75]. Specifically, it shows that the rate of critical
neurologic injury that causes cerebral palsy increases with
advancing gestational age [74] and suggests that the preg-
nancy complications (which precede preterm birth) are
Table 2: Numbers and rates of perinatal death, live birth and small for gestational age (SGA) live birth among twin births, Canada 
(excluding Ontario), 1991 to 1997.
Gestational age Stillbirths Neonatal deaths Live births SGA live births Rates (Conventional) Fetuses at 
risk†
Rates (Fetuses at risk)
SGA (%) Perinatal 
mortality per 
1,000
Births per 
1,000
R-SGA per 
1,000
Perinatal 
mortality per 
1,000
34 42 23 2513 447 17.9 25.4 29170 87.6 15.5 1.99
35 28 14 3302 740 22.5 12.6 26615 125.1 28.0 1.39
36 28 23 5372 1491 27.8 9.4 23285 231.9 64.5 1.85
37 29 15 6835 2249 33.0 6.4 17885 383.8 126.7 2.18
38 30 11 6720 2695 40.2 6.1 11021 612.5 246.5 3.45
39 15 7 2843 1291 45.5 7.7 4271 669.2 304.8 5.15
40 11 2 1246 641 51.5 10.3 1413 889.6 458.2 9.20
41 1 0 129 71 55.5 7.7 156 833.3 461.0 6.41
≥ 42 0 0 26 18 69.2 0.0 26 1000.0 692.3 0.00
Total‡ 703 869 34944 10325 29.9 44.1 35647 1000.0 298.8 44.1
Note: Perinatal mortality includes stillbirths and neonatal deaths. Live births at each gestation served as the denominator for the conventional SGA 
rate and total births at each gestational week served as the denominator for conventional perinatal mortality rate. Under the fetuses at risk 
approach, birth, revealed SGA (R-SGA) and perinatal mortality rates were calculated using the number of fetuses at risk at that gestation as the 
denominator for the rate.
† Calculated by summing the number of fetuses who delivered at that and subsequent gestational weeks.
‡ All gestational ages, including those < 34 weeks and those with missing gestational age.BMC Pregnancy and Childbirth 2007, 7:4 http://www.biomedcentral.com/1471-2393/7/4
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Schematic depiction of pregnancy course and options for calculating the incidence of various perinatal phenomena Figure 3
Schematic depiction of pregnancy course and options for calculating the incidence of various perinatal phe-
nomena. Schematic depiction of the course of several pregnancies illustrating the options for calculating the gestational age-
specific rate (incidence) of stillbirth (Figure 3a), preeclampsia (Figure 3b), obstetric intervention (Figure 3c), and revealed small-
for-gestational age (figure 3d). Figure 3a: Traditional calculation: Number of stillbirths at any gestational week/Number of total 
births at that gestational week = 1/4 = 250 per 1,000 total births in the first risk period and 1/5 = 200 per 1,000 total births in 
the second period. Fetuses at risk calculation: Number of stillbirths at any gestational week/Number of fetuses at risk of stillbirth 
at that gestational week = 1/16 = 63 per 1,000 fetuses at risk in the first risk period and 1/6 = 167 per 1,000 fetuses at risk in 
the second period. Figure 3b: Traditional calculation: Number of deliveries with preeclampsia at any gestational week/Number 
of deliveries at that gestational week = 1/4 = 250 per 1,000 deliveries for the first period and 1/5 = 200 per 1,000 deliveries for 
the second period.Fetuses at risk calculation: Number of new cases of preeclampsia at any gestational week/Number of pregnan-
cies at risk of preeclampsia at that gestational week = 1/16 = 63 per 1,000 pregnancies at risk in the first period and 1/6 = 167 
per 1,000 fetuses at risk in the second period. Figure 3c: Traditional calculation: Number of deliveries following labour induc-
tion or cesarean delivery at any gestational week/Number of deliveries at that gestational week = 2/4 = 500 per 1,000 deliver-
ies for the first risk period and 3/5 = 600 per 1,000 deliveries for the second period. Fetuses at risk calculation: Number of 
deliveries following labour induction or cesarean delivery at any gestational week/Number of pregnancies at risk of labour 
induction or cesarean delivery at that gestational week = 2/16 = 125 per 1,000 pregnancies at risk for the first period and 3/6 
= 500 per 1,000 pregnancies at risk for the second period.Figure 3d: Traditional calculation: SGA rate assumed to be uniform 
10% or 3% at each gestation depending on cutoff used (10th percentile or 3rd percentile). Fetuses at risk calculation: Number of 
new SGA cases at any gestational week/Number of fetuses at risk of SGA at that gestational week = 1/15 = 67 per 1,000 
fetuses at risk for the first risk period and 1/4 = 250 per 1,000 fetuses at risk for the second risk period. Fetuses at risk calcula-
tion for revealed SGA rate: Number of revealed SGA cases at any gestational week/Number of fetuses at risk of SGA birth at that 
gestational week = 2/16 = 125 per 1,000 fetuses at risk in the first risk period and 2/6 = 333 per 1,000 fetuses at risk in the sec-
ond period.
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Schematic depiction of the survival analysis (obstetric) model for perinatal death or serious neonatal morbidity Figure 4
Schematic depiction of the survival analysis (obstetric) model for perinatal death or serious neonatal morbid-
ity.  Schematic depiction of survival analysis model for perinatal death or serious neonatal morbidity with censoring at death or 
birth (whichever occurs earlier). Perinatal death and serious neonatal morbidity are assigned to the point of birth. In the first 
risk period, there are 16 fetuses at risk of perinatal death or serious neonatal morbidity, 3 births, 1 stillbirth, 1 neonatal death 
and 1 case of serious neonatal morbidity. In the second risk period, there are 7 fetuses at risk, 6 births, 1 stillbirth and 1 case 
of severe neonatal morbidity. Under the conventional calculation, with perinatal mortality defined as the number of perinatal 
deaths within any period divided by the number of total births in that period, the perinatal mortality/morbidity rate is 3/3 in the 
first risk period and 2/6 in the second. Note increase in denominator and decrease in rate from the first risk period to the sec-
ond risk period (from 100% to 33%). Under the fetuses at risk formulation, with perinatal mortality defined as the number of 
perinatal deaths in any period divided by the number of fetuses at risk of perinatal death in that period, the perinatal mortality/
morbidity rate is 3/16 in the first risk period and 2/7 in the second risk period. Note decrease in denominator and increase in 
rate from the first to the second risk period (from 19% to 29%).
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the cause of cerebral palsy (and not preterm birth itself).
With regards to fetal growth standards, the fetuses at risk
formulation shows that perinatal mortality patterns are
consistent with separate fetal growth standards for males
and females but not with the available separate standards
for blacks and whites in the United States [59].
The fetuses at risk formulation faces its most serious chal-
lenge from the traditional idea that perinatal mortality
declines as gestational age increases. Indeed, this latter
inference appears intuitive and is corroborated by the
readily apparent relationship between birth weight and
perinatal mortality. Despite the socially important prog-
nostic purpose served by the traditional model of perina-
tal death, it is not appropriate as a causal model. The use
of dual overlapping time scales for life in utero (gesta-
tional age) and after birth (chronologic age) and the trun-
cation of the full biologic continuum (as in the
calculation of neonatal mortality rates using live births at
a particular gestational age as the denominator) is prob-
lematic on the level of first principles and also because it
is responsible for numerous paradoxes and conundrums
[15]. The entire mortality experience of a cohort of fetuses
(as documented on single time scale) is of interest, irre-
spective of whether death precedes or follows birth (see
Figure 4).
As for explaining the rise in growth restriction and perina-
tal mortality rates with increasing gestation, one can spec-
ulate that the ability of the utero-placental system to
support the fetus declines with increasing gestational age.
Rising rates of growth restriction (as reflected in rising
rates of revealed SGA) and perinatal death with increasing
gestational duration reflect increases in the incidence of
pregnancy complications such as preeclampsia and chori-
oamnionitis [61,62] and also other stochastic processes
that adversely affect vascular function within the utero-
placental system.
The above-mentioned arguments suggest that the tradi-
tional and fetuses at risk models serve vastly different pur-
poses. The distinction between descriptive versus causal
models is particularly relevant in this context [76]; tradi-
tional models which truncate the biologic continuum are
better viewed as descriptive (noncausal) models which are
ideal for setting prognosis at birth, while the fetuses at risk
formulation represents a causal model that yields biologic
insights and provides the basis for obstetric intervention
[77].
2.3. An epidemiologic framework for medically indicated 
early delivery
Developing an explicit epidemiologic framework for justi-
fying medically indicated early delivery is important in
order to avoid conflicts between obstetric theory and prac-
tice [16]. Thus, in the absence of appropriate obstetric the-
ory, population increases in preterm birth (occurring
secondary to increases in medically indicated preterm
birth) may be viewed as adverse developments under the
traditional theoretical framework. This would lead to a
discounting of the perinatal mortality reductions that are
a consequence of recent changes in the management of
compromised fetuses at preterm gestation [1,4,7-9,21-
23]. Also, the obstetric literature needs to be more articu-
late with respect to the number of labor inductions and
cesarean deliveries that are needed to prevent one perina-
tal death or serious neonatal morbidity (given a particular
domain/indication). The proposed epidemiologic frame-
work based on the fetuses at risk model is illustrated
below using live births and stillbirths in the United States
between 1995–1996 and 1999–2000 (National Center
for Health Statistics perinatal mortality data file for all
states and the District of Columbia). Perinatal mortality
was defined to include stillbirths and neonatal deaths [11]
but excluded perinatal deaths due to congenital anoma-
lies (in order to eliminate the potential effect of temporal
increases in prenatal diagnosis and pregnancy termina-
tion for major congenital anomalies [78]).
2.3.1. Incidence of medically indicated early delivery, birth, revealed 
SGA, and death
The rate of labor induction and/or cesarean delivery
increased with increasing gestational age (Figure 5a),
being lowest among pregnancies with no medical risk fac-
tors and higher among pregnancies with complications.
The incidence of birth showed a similar pattern. The inci-
dence of revealed SGA rose with increasing gestational age
and was highest among twins and lowest among uncom-
plicated pregnancies (Figure 5b). Rates of perinatal death
also increased with increasing gestational age and patterns
were generally consistent with clinical expectation and
patterns of revealed SGA (Figure 5c).
2.3.2. Number needed to treat
The number needed to treat (NNT), an index widely used
in therapeutics as part of risk-benefit equations, is insuffi-
ciently articulated in connection with medically indicated
early delivery [79]. This is in part because conventional
models of perinatal mortality imply that early delivery is
associated with an increased rate of perinatal death (Fig-
ure 1b). Nevertheless, the concept of the NNT remains as
relevant and critical in the context of medically indicated
early delivery as elsewhere in medicine. The NNT for med-
ically indicated early delivery (given a specific indication)
may be defined as the reciprocal of the difference between
the rate of perinatal mortality or serious neonatal morbid-
ity given no obstetric intervention and the rate of perinatal
mortality or serious neonatal morbidity given medically
indicated early delivery.BMC Pregnancy and Childbirth 2007, 7:4 http://www.biomedcentral.com/1471-2393/7/4
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Incidence of labor induction/cesarean delivery, revealed small-for-gestation age (SGA) and perinatal death, United States 1999– 2000 Figure 5
Incidence of labor induction/cesarean delivery, revealed small-for-gestation age (SGA) and perinatal death, 
United States 1999–2000. Incidence of labor induction and/or cesarean delivery (Figure 5a), incidence of revealed SGA (Fig-
ure 5b) and incidence of perinatal death (Figure 5c) at 28 weeks gestation and over, among pregnancies with no medical risk 
factors, hypertension, hypertension and diabetes and twins, United States 1999–2000. Hypertension includes chronic and preg-
nancy-associated hypertension and eclampsia (National Center for Health Statistics definitions).
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2.3.3. Number needed to treat under different scenarios
The clinical scenarios described below are characterized
by varying background rates of perinatal mortality (which
substantially modify the NNT). The first scenario involves
an obstetric emergency (e.g., placental abruption with
fetal bradycardia) where a rapid absolute increase in the
(incidence density) rate of perinatal death is anticipated
over a short time span (minutes). It is expected that an
emergency cesarean delivery carried out within 15–30
minutes will prevent perinatal death in more than half the
fetuses [80]. This implies an NNT of approximately 2 or
less. Similarly, in a second scenario involving a serious
pregnancy complication and fetal compromise (e.g.,
severe preeclampsia with fetal growth restriction), an
expected perinatal mortality reduction due to labor induc-
tion and/or cesarean delivery (as opposed to no interven-
tion) of about 100 to 200 per 1,000 fetuses implies an
NNT of 5 to 10. A third scenario involves routine delivery
of twin pregnancy at 38 weeks gestation. If routine deliv-
ery at 38 weeks (relative to no obstetric intervention)
reduces the rate of perinatal mortality by about 5 per
1,000 fetuses, this implies an NNT of 200. The final sce-
nario involves routine delivery at 41 weeks gestation given
an uncomplicated singleton pregnancy. If the difference
between perinatal mortality given routine delivery at 41
weeks versus spontaneous delivery without obstetric
intervention is approximately 1 per 1,000 fetuses at risk,
this implies an NNT of 1,000. In other words, 1,000 rou-
tine early deliveries at 41 weeks gestation (through labor
induction and/or cesarean delivery) would prevent one
perinatal death.
2.3.4. Problems with the NNT calculation
Virtually all estimates used in the NNT calculations above
are speculative even if they represent more or less reason-
able approximations. In fact, most inputs into the NNT
calculation cannot be estimated given current standards of
care since the decision not to intervene is such situations
(e.g., severe preeclampsia with fetal compromise) would
constitute a breach of ethical standards.
2.3.5. Marginal NNT calculation
The marginal NNT, which measures the effect of increases
in medically indicated early delivery (beyond standard
rates of medically indicated early delivery), is an alterna-
tive measure that is directly pertinent to obstetric practice.
In this calculation, a temporal increase in medically indi-
cated early delivery is set against the change in perinatal
mortality in any particular domain.
Table 3 shows temporal changes in the incidence of
obstetric intervention and perinatal death in the United
States between 1995–96 and 1999–2000. The rate of
labor induction and/or cesarean delivery among singleton
pregnancies ≥ 28 weeks of gestation increased by 45.1 per
1,000 fetuses, from 339.4 per 1,000 fetuses in 1995–96 to
384.5 per 1,000 fetuses in 1999–2000 (P < 0.0001, Table
3). During the same period, the rate of perinatal death
(excluding deaths due to congenital anomalies) decreased
by 0.31 per 1,000 fetuses from 3.95 to 3.64 per 1,000
fetuses at ≥ 28 weeks of gestation (P < 0.0001). This
yielded a marginal NNT rate of (45.1/0.31) or 145. Thus,
145 additional labor inductions/cesarean deliveries in
1999–2000 (relative to 1995–96) were responsible for
preventing 1 perinatal death among singletons ≥ 28 weeks
gestation. Marginal NNT estimates for specific subpopula-
tions differed from those obtained for all singletons,
being as low as 32 among twins ≥ 28 weeks and as high
927 among singletons ≥ 34 weeks with hypertension
(Table 3).
Such marginal NNT calculations are analogous to calcula-
tions based on randomized trials which contrast routine
induction of labor vs selective induction of labor at or
beyond term [81] or those which contrast aggressive vs
expectant management given severe preeclampsia before
term gestation [82]. A meta-analysis [81] of studies on the
former issue showed that routine induction of labor
reduced perinatal death rates several-fold (odds ratio of
0.20, 95% confidence interval 0.06 to 0.70). This implies
an NNT of 1,250 for routine induction of labour at or
beyond term gestation, assuming a perinatal mortality
rate of 1.0 per 1,000 fetuses at risk following selective
labor induction.
2.3.6. Limitations
The proposed framework is based on two important
assumptions. First, medically indicated early delivery is
considered the final pathway for obstetric intervention.
Thus, increases in labor induction and cesarean delivery
are credited with preventing perinatal death even though
such early delivery was facilitated by improved methods
for assessing fetal well-being and supportive neonatal
care. Early delivery is thus viewed as a therapeutic package
which subsumes antenatal monitoring, diagnosis of fetal
well-being, supportive neonatal care and other interven-
tions that permit higher rates of early delivery to rescue
compromised fetuses from a hostile intrauterine environ-
ment.
A second assumption is that temporal increases in labor
induction and cesarean delivery rates and declines in peri-
natal mortality rates reflect true changes in obstetric prac-
tice (rather than changes in population characteristics). It
is possible that changes in maternal characteristics (such
as increases in older maternal age and pre-pregnancy
obesity [83,84]) may have been partly responsible for
changes in labor induction, cesarean delivery and perina-
tal mortality rates in the United States between 1995–96
and 1999–2000. Although such changes are unlikely toBMC Pregnancy and Childbirth 2007, 7:4 http://www.biomedcentral.com/1471-2393/7/4
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have affected the results substantially (since the study
interval was only 4 years), regression adjustment can be
used to address this issue where necessary.
Current limitations of the fetuses at risk approach include
an inability to precisely document the incidence of fetal
growth restriction. This is because diagnosis of growth fal-
tering in utero, although much facilitated in recent dec-
ades through ultrasonographic means, remains inaccurate
and essentially unavailable at the population level [63-
65]. The alternative index of revealed SGA [15] is useful
but limited by its relationship to birth rate patterns. Fur-
ther developments in ultrasound technology are needed
so that incidence rates can be estimated more accurately
based on an identification of all new cases of growth
restriction (in utero). Another approximation in the
fetuses at risk approach relates to the timing of the patho-
logic process or event. Assigning events such as neonatal
death and serious neonatal morbidity to the moment of
birth often involves a systematic overestimation of the
timing of the critical pathologic process or event [74]. The
systematic nature of the problem means that the inci-
dence patterns of perinatal mortality and morbidity are
not seriously affected, however.
3. Summary
The cornerstone of modern obstetrics, namely, early deliv-
ery given fetal compromise, cannot be reconciled with tra-
ditional models of perinatal mortality which show that
perinatal death rates decline exponentially as gestational
duration increases. On the other hand, the fetuses at risk
approach, which shows that pregnancy complications,
revealed SGA and perinatal death rates increase with
increasing gestational age, provides a justification for
medically indicated early delivery and also resolves sev-
eral prevailing conundrums in the perinatal field.
Although inputs for estimating therapeutic indices related
to medically indicated early delivery (such as the NNT)
cannot be obtained for ethical reasons, it is possible to ret-
rospectively estimate the marginal NNT associated with
medically indicated early delivery. This provides an esti-
mate of the number of additional medically indicated
early deliveries that were required to prevent one perinatal
death. On a more general level, the traditional model of
perinatal death and the fetuses at risk approach are best
viewed as serving different purposes; the former is suited
for setting prognosis at birth while the latter provides a
causal framework and the basis for obstetric intervention.
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